Volume 1/ Number 1/ January 2001

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FEMORAL VEIN CANNULATION DURING RESUSCITATION: POTENTIAL ADVANTAGES

 

Central Vein Cannulation is often recommended during cardiopulmonary resuscitation. Both the American and European Resuscitation Society agree that it presents a fast, reliable, and with some drugs like Cathecol-amines, it could be even safer than peripheral veins. In their guidelines, the recommended routes are the internal jugular or subclavian veins. However these routes are close to the chest, which interferes with the on going chest compression and intubation. These are often interrupted to allow for a steady venous cannulation procedure.

We have often found the femoral approach to be very rewarding for several reasons. It is as easy as the jugular or subclavian routes, but without some of the risks and complications, like pneumothorax. Pneumothorax during cardiopulmonary arrest is difficult to diagnose and if unnoticed can lead to death of the victim despite an otherwise adequate resuscitation. I am not aware of any studies into the frequency of this complication not only in survivors of CPR, but also in those who succumb. Unwanted arterial puncture is probably as common in the femoral route as the other two sites, but vessel compression is easier and the consequences of hematoma in the groin are less serious than in the neck. In fact, if the femoral artery is punctured, we often leave an arterial line for accurate and continuous blood pressure and gas monitoring. The same cannot be applied to puncture of the subclavian or carotid artery.

Clearly, one must pay more attention to cleaning and disinfection of the groin. Although infection is said to be more common after femoral cannulation, but to my knowledge, there are no properly controlled studies to support this view. Seneff suggests that the incidence of infection is similar(1). Likewise there are no studies to look at the bio-availability of drugs given through femoral, versus subclavian or jugular routes.

One may argue that chest compression during CPR may improve the distribution of drugs given through the superior as opposed to inferior Vena Cava. However, this is not known. Likewise, it is also not known if abdominal "counter compression" improves the distribution of drugs given by the femoral route.

Finally, measurement of central venous pressure (CVP) in the resuscitated patient is one of the aims of central venous cannulation. Certainly there should be no difference between the various routes provided the catheter tip is situated in the right atrium. However, is there a difference between measurements of CVP in the inferior or superior vena cava? A study by Kwok et al suggested no difference(2) and we are contemplating a similar study in elective patients.

In conclusion, in the setting of Cardiopulmonary Resuscitation, there are some advantages using the femoral vein for central venous cannulation. Mainly due to less interference with intubation and chest compression and with respect to some complications. I feel that personnel involved in advanced resuscitation should be aware of these advantages and possibly trained in the basic technique of femoral route. It may be early to suggest including the femoral cannulation in any guidelines, but I welcome the comments of colleagues, especially if studies should be instigated to evaluate the advantages of the femoral route compared to the established routes of jugular and or subclavian veins.

References: